Loading…
Mark Douglas Smith is Director at Jazz Pharmaceuticals. OQRO lists 4 transactions filed with the SEC under this name, the latest on Sep 3, 2026, each linked to the official Form 4.
Director
Disclosures on record
4
Companies involved
1
Jazz PharmaceuticalsJAZZ
4 disclosures · Jun 2026 – Sep 2026 · 1 sold
Aug 31, 202614disclosed Sep 3
DetailsOfficial recordAug 31, 20261,692disclosed Sep 3
DetailsOfficial recordJun 15, 2026Sold~$267Kdisclosed Jun 18
DetailsOfficial record